{
  "en": [
    {
      "id": 1890,
      "title": "Association Between Opioid Use and the Development of Diverticulitis",
      "url": "https://www.cadth.ca/association-between-opioid-use-and-development-diverticulitis",
      "therapeuticArea": "Gastrointestinal",
      "responseTeam": "CNODES",
      "startDate": "9-Dec-22",
      "projectedCompletion": "Fall 2024",
      "status": "Complete",
      "language": "en",
      "lastUpdated": "2025-03-07T16:24:15.204Z"
    },
    {
      "id": 1891,
      "title": "Biologic Drugs for Severe Asthma",
      "url": "https://www.cadth.ca/biologic-drugs-severe-asthma",
      "therapeuticArea": "Respiratory",
      "responseTeam": "ADTEC",
      "startDate": "1-Mar-23",
      "projectedCompletion": "Fall 2023",
      "status": "Complete",
      "language": "en",
      "lastUpdated": "2025-03-07T16:24:15.237Z"
    },
    {
      "id": 1892,
      "title": "Efficacy and Safety of Long-Term Use of Omalizumab for the Treatment of Chronic Idiopathic Urticaria",
      "url": "https://www.cadth.ca/efficacy-and-safety-long-term-use-omalizumab-treatment-chronic-idiopathic-urticaria",
      "therapeuticArea": "Allergy and Immunology",
      "responseTeam": "PODET",
      "startDate": "2-Mar-23",
      "projectedCompletion": "Spring 2024",
      "status": "Complete",
      "language": "en",
      "lastUpdated": "2025-03-07T16:24:15.268Z"
    },
    {
      "id": 1893,
      "title": "The Incidence and Prevalence of the Long-Term Use of Omalizumab for Chronic Idiopathic Urticaria",
      "url": "https://www.cadth.ca/incidence-and-prevalence-long-term-use-omalizumab-chronic-idiopathic-urticaria",
      "therapeuticArea": "Allergy and Immunology",
      "responseTeam": "Contractor",
      "startDate": "16-Mar-23",
      "projectedCompletion": "Spring 2024",
      "status": "Complete",
      "language": "en",
      "lastUpdated": "2025-03-07T16:24:15.299Z"
    },
    {
      "id": 1894,
      "title": "Treatment of Chronic Pain in Patients on Opioid Agonist Therapy or with Opioid Use Disorder",
      "url": "https://www.cadth.ca/treatment-chronic-pain-patients-opioid-agonist-therapy-or-opioid-use-disorder",
      "therapeuticArea": "Pain and Pain Management",
      "responseTeam": "Contractor",
      "startDate": "29-May-23",
      "projectedCompletion": "Summer 2024",
      "status": "Complete",
      "language": "en",
      "lastUpdated": "2025-03-07T16:24:15.331Z"
    },
    {
      "id": 1895,
      "title": "The Safety of Niraparib in Ovarian Cancer",
      "url": "https://www.cadth.ca/safety-niraparib-ovarian-cancer",
      "therapeuticArea": "Oncology",
      "responseTeam": "CCRE, Exactis",
      "startDate": "8-Feb-23",
      "projectedCompletion": "Fall 2023",
      "status": "Complete",
      "language": "en",
      "lastUpdated": "2025-03-07T16:24:15.365Z"
    },
    {
      "id": 1896,
      "title": "The Safety of Tofacitinib in Patients with Ulcerative Colitis",
      "url": "https://www.cadth.ca/utilization-analysis-tofacitinib-and-other-drugs-among-individuals-ulcerative-colitis-feasibility",
      "therapeuticArea": "Gastrointestinal",
      "responseTeam": "CNODES, CAN-AIM",
      "startDate": "24-Feb-23",
      "projectedCompletion": "Winter 2023",
      "status": "Complete",
      "language": "en",
      "lastUpdated": "2025-03-07T16:24:15.397Z"
    },
    {
      "id": 1897,
      "title": "Trends in Opioid and Opioid Agonist Therapy Prescribing and Associated Harms in Canada",
      "url": "https://www.cadth.ca/trends-opioid-and-opioid-agonist-therapy-prescribing-and-associated-harms-canada",
      "therapeuticArea": "Pain and Pain Management",
      "responseTeam": "Contractor",
      "startDate": "17-Oct-23",
      "projectedCompletion": "Winter 2025",
      "status": "Complete",
      "language": "en",
      "lastUpdated": "2025-03-07T16:24:15.430Z"
    },
    {
      "id": 1898,
      "title": "The Use of Oral Fluoroquinolones in Canada: Drug Utilization Study Update",
      "url": "https://www.cadth.ca/use-oral-fluoroquinolones-canada-drug-utilization-study-update",
      "therapeuticArea": "Infectious Disease",
      "responseTeam": "CNODES",
      "startDate": "6-Oct-23",
      "projectedCompletion": "Summer 2024",
      "status": "Complete",
      "language": "en",
      "lastUpdated": "2025-03-07T16:24:15.464Z"
    },
    {
      "id": 1899,
      "title": "Immune Checkpoint Inhibitors for Non–Small Cell Lung Cancer With Genomic Aberrations",
      "url": "https://www.cadth.ca/immune-checkpoint-inhibitors-non-small-cell-lung-cancer-genomic-aberrations",
      "therapeuticArea": "Oncology",
      "responseTeam": "PODET",
      "startDate": "14-Nov-23",
      "projectedCompletion": "Summer 2024",
      "status": "Complete",
      "language": "en",
      "lastUpdated": "2025-03-07T16:24:15.499Z"
    },
    {
      "id": 1900,
      "title": "Buprenorphine Formulations for Opioid Use Disorder",
      "url": "https://www.cadth.ca/buprenorphine-formulations-opioid-use-disorder",
      "therapeuticArea": "Pain and Pain Management",
      "responseTeam": "Dr. Michael Law",
      "startDate": "10-Nov-23",
      "projectedCompletion": "Winter 2024",
      "status": "Complete",
      "language": "en",
      "lastUpdated": "2025-03-07T16:24:15.530Z"
    },
    {
      "id": 1901,
      "title": "New Drugs for Relapsed or Refractory Peripheral T-cell Lymphoma",
      "url": "https://www.cadth.ca/emerging-drugs-relapsed-or-refractory-peripheral-t-cell-lymphoma",
      "therapeuticArea": "Oncology",
      "responseTeam": "Dr. Michael Law",
      "startDate": "20-Jan-23",
      "projectedCompletion": "Spring 2023",
      "status": "Complete",
      "language": "en",
      "lastUpdated": "2025-03-07T16:24:15.562Z"
    },
    {
      "id": 1902,
      "title": "Evidence Review of Treatment Options for Uncomplicated Gonococcal Infections",
      "url": "https://www.cda-amc.ca/evidence-review-treatment-options-uncomplicated-gonococcal-infections",
      "therapeuticArea": "Infectious Disease",
      "responseTeam": "Contractor",
      "startDate": "20-Jan-23",
      "projectedCompletion": "Summer 2023",
      "status": "Complete",
      "language": "en",
      "lastUpdated": "2025-03-07T16:24:15.594Z"
    },
    {
      "id": 1903,
      "title": "Remdesivir (Veklury) for the Treatment of COVID-19 in the Inpatient Setting",
      "url": "https://www.cadth.ca/review-covid-19-therapies-0",
      "therapeuticArea": "Infectious Disease",
      "responseTeam": "PODET",
      "startDate": "2-May-23",
      "projectedCompletion": "Summer 2023",
      "status": "Complete",
      "language": "en",
      "lastUpdated": "2025-03-07T16:24:15.625Z"
    },
    {
      "id": 1904,
      "title": "Tocilizumab (Actemra) for the Treatment of Hospitalized Patients With COVID-19",
      "url": "https://www.cadth.ca/review-covid-19-therapies-0",
      "therapeuticArea": "Infectious Disease",
      "responseTeam": "Contractor",
      "startDate": "2-May-23",
      "projectedCompletion": "Summer 2023",
      "status": "Complete",
      "language": "en",
      "lastUpdated": "2025-03-07T16:24:15.658Z"
    },
    {
      "id": 1905,
      "title": "Remdesivir (Veklury) for the Treatment of COVID-19 in the Outpatient Setting",
      "url": "https://www.cadth.ca/review-covid-19-therapies-0",
      "therapeuticArea": "Infectious Disease",
      "responseTeam": "PODET",
      "startDate": "4-May-23",
      "projectedCompletion": "Summer 2023",
      "status": "Complete",
      "language": "en",
      "lastUpdated": "2025-03-07T16:24:15.689Z"
    },
    {
      "id": 1906,
      "title": "Nirmatrelvir-Ritonavir (Paxlovid) for the Treatment of COVID-19",
      "url": "https://www.cadth.ca/review-covid-19-therapies-0",
      "therapeuticArea": "Infectious Disease",
      "responseTeam": "ADTEC",
      "startDate": "4-May-23",
      "projectedCompletion": "Summer 2023",
      "status": "Complete",
      "language": "en",
      "lastUpdated": "2025-03-07T16:24:15.723Z"
    },
    {
      "id": 1907,
      "title": "Buprenorphine-Based Formulations for Opioid Use Disorder in Correctional Settings",
      "url": "https://www.cadth.ca/buprenorphine-based-formulations-opioid-use-disorder-correctional-settings",
      "therapeuticArea": "Pain and Pain Management",
      "responseTeam": "Contractor",
      "startDate": "17-Nov-23",
      "projectedCompletion": "Spring 2024",
      "status": "Complete",
      "language": "en",
      "lastUpdated": "2025-03-07T16:24:15.756Z"
    },
    {
      "id": 1908,
      "title": "Immune checkpoint inhibitors for mutated non–small cell lung cancer",
      "url": "https://www.cda-amc.ca/utilization-cancer-therapies-advanced-non-small-cell-lung-cancer-oncogenic-driver-mutation",
      "therapeuticArea": "Oncology",
      "responseTeam": "CCRE, Exactis",
      "startDate": "7-Dec-23",
      "projectedCompletion": "Summer 2024",
      "status": "Complete",
      "language": "en",
      "lastUpdated": "2025-03-07T16:24:15.788Z"
    },
    {
      "id": 1909,
      "title": "Safety of Ozempic for Type II Diabetes",
      "url": "https://www.cadth.ca/safety-ozempic-type-ii-diabetes",
      "therapeuticArea": "Diabetes",
      "responseTeam": "CNODES",
      "startDate": "4-Dec-23",
      "projectedCompletion": "Summer 2024",
      "status": "Complete",
      "language": "en",
      "lastUpdated": "2025-03-07T16:24:15.820Z"
    },
    {
      "id": 1910,
      "title": "Calcitonin Gene-Related Peptide Inhibitors for Migraine Prophylaxis",
      "url": "https://www.cadth.ca/calcitonin-gene-related-peptide-inhibitors-migraine-prophylaxis",
      "therapeuticArea": "Pain and Pain Management",
      "responseTeam": "Contractor, ADTEC, CAN-AIM",
      "startDate": "2-Feb-24",
      "projectedCompletion": "Winter 2025",
      "status": "Complete",
      "language": "en",
      "lastUpdated": "2025-03-07T16:24:15.851Z"
    },
    {
      "id": 1911,
      "title": "Efficacy and Safety of Treatment Options for Uncomplicated Gonococcal Infections",
      "url": "https://www.cda-amc.ca/efficacy-and-safety-treatment-options-uncomplicated-gonococcal-infections",
      "therapeuticArea": "Infectious Disease",
      "responseTeam": "Contractor",
      "startDate": "8-Jan-24",
      "projectedCompletion": "Summer 2024",
      "status": "Complete",
      "language": "en",
      "lastUpdated": "2025-03-07T16:24:15.885Z"
    },
    {
      "id": 1912,
      "title": "Switching Calcitonin Gene–Related Peptide Inhibitors for Migraine Prophylaxis",
      "url": "https://www.cda-amc.ca/switching-calcitonin-gene-related-peptide-inhibitors-migraine-prophylaxis",
      "therapeuticArea": "Pain and Pain Management",
      "responseTeam": "Dr. Michael Law",
      "startDate": "29-Jan-24",
      "projectedCompletion": "Summer 2024",
      "status": "Complete",
      "language": "en",
      "lastUpdated": "2025-03-07T16:24:15.918Z"
    },
    {
      "id": 1913,
      "title": "Drugs for Metastatic Renal Cell Carcinoma: Utilization Analysis",
      "url": "https://www.cadth.ca/drugs-metastatic-renal-cell-carcinoma-utilization-analysis",
      "therapeuticArea": "Oncology",
      "responseTeam": "CCRE",
      "startDate": "3-Apr-24",
      "projectedCompletion": "Winter 2025",
      "status": "Complete",
      "language": "en",
      "lastUpdated": "2025-03-07T16:24:15.949Z"
    },
    {
      "id": 1914,
      "title": "Utilization of Antidiabetic Drugs during Pregnancy",
      "url": "https://www.cadth.ca/utilization-antidiabetic-drugs-during-pregnancy",
      "therapeuticArea": "Diabetes",
      "responseTeam": "CNODES",
      "startDate": "4-Mar-24",
      "projectedCompletion": "Winter 2025",
      "status": "Complete",
      "language": "en",
      "lastUpdated": "2025-03-07T16:24:15.981Z"
    },
    {
      "id": 1915,
      "title": "GLP-1 Receptor Agonists and Self-Harm",
      "url": "https://cda-amc.ca/glp-1-receptor-agonists-and-self-harm",
      "therapeuticArea": "Diabetes",
      "responseTeam": "CNODES",
      "startDate": "30-Jan-24",
      "projectedCompletion": "Winter 2025",
      "status": "Active",
      "language": "en",
      "lastUpdated": "2025-03-07T16:24:16.013Z"
    },
    {
      "id": 1916,
      "title": "Exploration of the Risk of Suicidality and Self-Harm With Glucagon-Like Peptide-1 Receptor Agonists",
      "url": "https://www.cadth.ca/exploration-risk-suicidality-and-self-harm-glucagon-peptide-1-receptor-agonists",
      "therapeuticArea": "Diabetes",
      "responseTeam": "CNODES",
      "startDate": "30-Jan-24",
      "projectedCompletion": "Spring 2024",
      "status": "Complete",
      "language": "en",
      "lastUpdated": "2025-03-07T16:24:16.043Z"
    },
    {
      "id": 1917,
      "title": "Long-Acting Inhaled Drugs for Chronic Obstructive Pulmonary Disease",
      "url": "https://www.cda-amc.ca/long-acting-inhaled-drugs-chronic-obstructive-pulmonary-disease",
      "therapeuticArea": "Respiratory",
      "responseTeam": "PODET, ADTEC",
      "startDate": "15-Nov-23",
      "projectedCompletion": "Spring 2026",
      "status": "Active",
      "language": "en",
      "lastUpdated": "2025-03-07T16:24:16.075Z"
    },
    {
      "id": 1918,
      "title": "Patterns in Utilization of Long-Acting Inhaled Drugs for the Treatment of Chronic Obstructive Pulmonary Disease",
      "url": "https://www.cadth.ca/patterns-utilization-long-acting-inhaled-drugs-treatment-chronic-obstructive-pulmonary-disease",
      "therapeuticArea": "Respiratory",
      "responseTeam": "CNODES",
      "startDate": "15-Nov-23",
      "projectedCompletion": "Spring 2025",
      "status": "Active",
      "language": "en",
      "lastUpdated": "2025-03-07T16:24:16.108Z"
    },
    {
      "id": 1919,
      "title": "Outpatient Nirmatrelvir-Ritonavir and Remdesivir Utilization in Canada",
      "url": "https://www.cadth.ca/review-covid-19-therapies-0",
      "therapeuticArea": "Infectious Disease",
      "responseTeam": "CNODES",
      "startDate": "2-May-23",
      "projectedCompletion": "Summer 2023",
      "status": "Complete",
      "language": "en",
      "lastUpdated": "2025-03-07T16:24:16.139Z"
    },
    {
      "id": 1920,
      "title": "The Utilization of PCSK9 Inhibitors in Familial Hypercholesterolemia",
      "url": "https://www.cda-amc.ca/utilization-pcsk9-inhibitors-familial-hypercholesterolemia",
      "therapeuticArea": "Cardiovascular",
      "responseTeam": "CNODES",
      "startDate": "7-Jun-24",
      "projectedCompletion": "Fall 2024",
      "status": "Complete",
      "language": "en",
      "lastUpdated": "2025-03-07T16:24:16.170Z"
    },
    {
      "id": 1921,
      "title": "BRAF and MEK Inhibitors for Active or Symptomatic Melanoma Brain Metastasis",
      "url": "https://www.cda-amc.ca/braf-and-mek-inhibitors-active-or-symptomatic-melanoma-brain-metastasis",
      "therapeuticArea": "Oncology",
      "responseTeam": "PODET",
      "startDate": "15-Jun-24",
      "projectedCompletion": "Summer 2024",
      "status": "Complete",
      "language": "en",
      "lastUpdated": "2025-03-07T16:24:16.202Z"
    },
    {
      "id": 1922,
      "title": "Early Biologic Treatment for Inflammatory Bowel Disease",
      "url": "https://www.cda-amc.ca/early-biologic-treatment-inflammatory-bowel-disease",
      "therapeuticArea": "Gastrointestinal",
      "responseTeam": "PODET",
      "startDate": "4-Jul-24",
      "projectedCompletion": "Summer 2024",
      "status": "Complete",
      "language": "en",
      "lastUpdated": "2025-03-07T16:24:16.234Z"
    },
    {
      "id": 1923,
      "title": "The Effectiveness of PCSK9 Inhibitors in Familial Hypercholesterolemia",
      "url": "https://www.cadth.ca/effectiveness-pcsk9-inhibitors-familial-hypercholesterolemia",
      "therapeuticArea": "Cardiovascular",
      "responseTeam": "CNODES, ADTEC",
      "startDate": "8-Aug-24",
      "projectedCompletion": "Summer 2025",
      "status": "Active",
      "language": "en",
      "lastUpdated": "2025-03-07T16:24:16.265Z"
    },
    {
      "id": 1924,
      "title": "Re-treatment With Immune Checkpoint Inhibitors: Utilization Analysis",
      "url": "https://www.cda-amc.ca/re-treatment-immune-checkpoint-inhibitors-utilization-analysis",
      "therapeuticArea": "Oncology",
      "responseTeam": "CCRE",
      "startDate": "15-Aug-24",
      "projectedCompletion": "Summer 2025",
      "status": "Active",
      "language": "en",
      "lastUpdated": "2025-03-07T16:24:16.312Z"
    },
    {
      "id": 1925,
      "title": "Comparative Evidence Between Transdermal and Oral Menopausal Hormone Therapy",
      "url": null,
      "therapeuticArea": "Endocrinology",
      "responseTeam": "PODET",
      "startDate": "24-Sep-24",
      "projectedCompletion": "Winter 2025",
      "status": "Active",
      "language": "en",
      "lastUpdated": "2025-03-07T16:24:16.343Z"
    },
    {
      "id": 1926,
      "title": "Comparative Evidence Between Transdermal and Oral Estrogen Therapy as part of Gender-Affirming Care",
      "url": null,
      "therapeuticArea": "Endocrinology",
      "responseTeam": "PODET",
      "startDate": "24-Sep-24",
      "projectedCompletion": "Winter 2025",
      "status": "Active",
      "language": "en",
      "lastUpdated": "2025-03-07T16:24:16.375Z"
    },
    {
      "id": 1927,
      "title": "Utilization of Long-Acting Injectable Antipsychotics",
      "url": "https://www.cda-amc.ca/utilization-long-acting-injectable-antipsychotics",
      "therapeuticArea": "Mental Health",
      "responseTeam": "ODPRN, ADTEC",
      "startDate": "23-Oct-24",
      "projectedCompletion": "Spring 2025",
      "status": "Active",
      "language": "en",
      "lastUpdated": "2025-03-07T16:24:16.406Z"
    },
    {
      "id": 1928,
      "title": "Emerging Antiviral Drugs to Prevent or Treat Influenza",
      "url": "https://www.cda-amc.ca/emerging-antiviral-drugs-prevent-or-treat-influenza",
      "therapeuticArea": "Infectious Disease",
      "responseTeam": "PMDE",
      "startDate": "4-Nov-24",
      "projectedCompletion": "Fall 2024",
      "status": "Complete",
      "language": "en",
      "lastUpdated": "2025-03-07T16:24:16.437Z"
    },
    {
      "id": 1929,
      "title": "Antiviral Drugs for Post-Exposure Prophylaxis Influenza A or Influenza B",
      "url": null,
      "therapeuticArea": "Infectious Disease",
      "responseTeam": "Dr. Michael Law",
      "startDate": "11-Dec-24",
      "projectedCompletion": "Spring 2025",
      "status": "Active",
      "language": "en",
      "lastUpdated": "2025-03-07T16:24:16.467Z"
    },
    {
      "id": 1930,
      "title": "Antiviral Drugs for Zoonotic Influenza",
      "url": null,
      "therapeuticArea": "Infectious Disease",
      "responseTeam": "ADTEC",
      "startDate": "2-Dec-24",
      "projectedCompletion": "Spring 2025",
      "status": "Active",
      "language": "en",
      "lastUpdated": "2025-03-07T16:24:16.501Z"
    },
    {
      "id": 1931,
      "title": "Cost-Effectiveness of Antiviral Drugs to Prevent or Treat Influenza A, Influenza B or Zoonotic Influenza",
      "url": null,
      "therapeuticArea": "Infectious Disease",
      "responseTeam": "ADTEC",
      "startDate": "9-Dec-24",
      "projectedCompletion": "Spring 2025",
      "status": "Active",
      "language": "en",
      "lastUpdated": "2025-03-07T16:24:16.531Z"
    },
    {
      "id": 1932,
      "title": "Trends in hydromorphone prescribing in Canada from 2018 to 2024",
      "url": "https://www.cda-amc.ca/trends-hydromorphone-prescribing-canada-2018-2024",
      "therapeuticArea": "Pain and Pain Management",
      "responseTeam": "ODPRN",
      "startDate": "2-Dec-24",
      "projectedCompletion": "Summer 2025",
      "status": "Active",
      "language": "en",
      "lastUpdated": "2025-03-07T16:24:16.562Z"
    }
  ],
  "fr": [
    {
      "id": 1933,
      "title": "Le lien entre la consommation d’opioïdes et l’apparition d’une diverticulite",
      "url": "https://www.cadth.ca/fr/le-lien-entre-la-consommation-dopioides-et-lapparition-dune-diverticulite",
      "therapeuticArea": "Gastro-intestinal",
      "responseTeam": "RCEOM",
      "startDate": "9-Dec-22",
      "projectedCompletion": "Automne 2024",
      "status": "Complete",
      "language": "fr",
      "lastUpdated": "2025-03-07T16:24:16.821Z"
    },
    {
      "id": 1934,
      "title": "Les produits biologiques contre l’asthme grave",
      "url": "https://www.cadth.ca/fr/les-medicaments-biologiques-contre-lasthme-grave",
      "therapeuticArea": "Respiratoire",
      "responseTeam": "ADTEC",
      "startDate": "1-Mar-23",
      "projectedCompletion": "Automne 2023",
      "status": "Complete",
      "language": "fr",
      "lastUpdated": "2025-03-07T16:24:16.852Z"
    },
    {
      "id": 1935,
      "title": "L’efficacité et l’innocuité du recours prolongé à l’omalizumab dans le traitement de l’urticaire chronique idiopathique",
      "url": "https://www.cadth.ca/fr/lefficacite-et-linnocuite-du-recours-prolonge-lomalizumab-dans-le-traitement-de-lurticaire",
      "therapeuticArea": "Allergie et immunologie",
      "responseTeam": "PODET",
      "startDate": "2-Mar-23",
      "projectedCompletion": "Printemps 2024",
      "status": "Complete",
      "language": "fr",
      "lastUpdated": "2025-03-07T16:24:16.883Z"
    },
    {
      "id": 1936,
      "title": "L’incidence et la prévalence du recours prolongé à l’omalizumab dans le traitement de l’urticaire chronique idiopathique",
      "url": "https://www.cadth.ca/fr/lincidence-et-la-prevalence-du-recours-prolonge-lomalizumab-dans-le-traitement-de-lurticaire",
      "therapeuticArea": "Allergie et immunologie",
      "responseTeam": "Fournisseur externe",
      "startDate": "16-Mar-23",
      "projectedCompletion": "Hiver 2024",
      "status": "Complete",
      "language": "fr",
      "lastUpdated": "2025-03-07T16:24:16.914Z"
    },
    {
      "id": 1937,
      "title": "Le traitement de la douleur chronique chez les patients suivant un traitement par agonistes des opioïdes ou ayant un trouble de consommation d’opioïdes",
      "url": "https://www.cadth.ca/fr/le-traitement-de-la-douleur-chronique-chez-les-patients-suivant-un-traitement-par-agonistes-des",
      "therapeuticArea": "Douleur et soulagement de la douleur",
      "responseTeam": "Fournisseur externe",
      "startDate": "29-May-23",
      "projectedCompletion": "Printemps 2024",
      "status": "Complete",
      "language": "fr",
      "lastUpdated": "2025-03-07T16:24:16.945Z"
    },
    {
      "id": 1938,
      "title": "L’innocuité du niraparib dans le traitement du cancer de l’ovaire",
      "url": "https://www.cadth.ca/fr/linnocuite-du-niraparib-dans-le-traitement-du-cancer-de-lovaire",
      "therapeuticArea": "Oncologie",
      "responseTeam": "CCRE, Exactis",
      "startDate": "8-Feb-23",
      "projectedCompletion": "Automne 2023",
      "status": "Complete",
      "language": "fr",
      "lastUpdated": "2025-03-07T16:24:16.976Z"
    },
    {
      "id": 1939,
      "title": "L’innocuité du tofacitinib dans le traitement de la colite ulcéreuse",
      "url": "https://www.cadth.ca/fr/analyse-de-lutilisation-du-tofacitinib-et-dautres-medicaments-chez-les-personnes-atteintes-de",
      "therapeuticArea": "Gastro-intestinal",
      "responseTeam": "RCEOM, CAN-AIM",
      "startDate": "24-Feb-23",
      "projectedCompletion": "Hiver 2023",
      "status": "Complete",
      "language": "fr",
      "lastUpdated": "2025-03-07T16:24:17.007Z"
    },
    {
      "id": 1940,
      "title": "Les tendances de prescription d’opioïdes et de traitements par agonistes opioïdes et les effets néfastes connexes au Canada",
      "url": "https://www.cadth.ca/fr/les-tendances-de-prescription-dopioides-et-de-traitements-par-agonistes-opioides-et-les-effets",
      "therapeuticArea": "Douleur et soulagement de la douleur",
      "responseTeam": "Fournisseur externe",
      "startDate": "17-Oct-23",
      "projectedCompletion": "Hiver 2025",
      "status": "Complete",
      "language": "fr",
      "lastUpdated": "2025-03-07T16:24:17.038Z"
    },
    {
      "id": 1941,
      "title": "Le recours aux fluoroquinolones au Canada : mise à jour d’une étude d’utilisation",
      "url": "https://www.cadth.ca/fr/le-recours-aux-fluoroquinolones-prise-orale-au-canada-mise-jour-dune-etude-dutilisation",
      "therapeuticArea": "Maladies infectieuses",
      "responseTeam": "RCEOM",
      "startDate": "6-Oct-23",
      "projectedCompletion": "Été 2024",
      "status": "Complete",
      "language": "fr",
      "lastUpdated": "2025-03-07T16:24:17.069Z"
    },
    {
      "id": 1942,
      "title": "Les inhibiteurs de points de contrôle immunitaire dans le cancer du poumon non à petites cellules présentant des aberrations génomiques",
      "url": "https://www.cadth.ca/fr/les-inhibiteurs-de-points-de-controle-immunitaire-dans-le-cancer-du-poumon-non-petites-cellules",
      "therapeuticArea": "Oncologie",
      "responseTeam": "PODET",
      "startDate": "14-Nov-23",
      "projectedCompletion": "Été 2024",
      "status": "Complete",
      "language": "fr",
      "lastUpdated": "2025-03-07T16:24:17.100Z"
    },
    {
      "id": 1943,
      "title": "Les préparations de buprénorphine dans le traitement du trouble de l’usage d’opioïdes",
      "url": "https://www.cadth.ca/fr/les-preparations-de-buprenorphine-dans-le-traitement-du-trouble-de-lusage-dopioides",
      "therapeuticArea": "Douleur et soulagement de la douleur",
      "responseTeam": "Dr. Michael Law",
      "startDate": "10-Nov-23",
      "projectedCompletion": "Hiver 2024",
      "status": "Complete",
      "language": "fr",
      "lastUpdated": "2025-03-07T16:24:17.131Z"
    },
    {
      "id": 1944,
      "title": "Les nouveaux médicaments contre le lymphome T périphérique récidivant ou réfractaire",
      "url": "https://www.cadth.ca/fr/les-nouveaux-medicaments-contre-le-lymphome-t-peripherique-recidivant-ou-refractaire",
      "therapeuticArea": "Oncologie",
      "responseTeam": "Dr. Michael Law",
      "startDate": "20-Jan-23",
      "projectedCompletion": "Printemps 2023",
      "status": "Complete",
      "language": "fr",
      "lastUpdated": "2025-03-07T16:24:17.161Z"
    },
    {
      "id": 1945,
      "title": "Examen des données probantes sur le traitement de la gonorrhée sans complication",
      "url": "https://www.cadth.ca/fr/examen-des-donnees-probantes-en-vue-de-lelaboration-de-recommandations-sur-le-traitement-de-la",
      "therapeuticArea": "Maladies infectieuses",
      "responseTeam": "Fournisseur externe",
      "startDate": "20-Jan-23",
      "projectedCompletion": "Été 2023",
      "status": "Complete",
      "language": "fr",
      "lastUpdated": "2025-03-07T16:24:17.192Z"
    },
    {
      "id": 1946,
      "title": "Le remdésivir (Veklury) dans le traitement de la COVID-19 chez le patient hospitalisé",
      "url": "https://www.cadth.ca/fr/examen-des-traitements-contre-la-covid-19-0",
      "therapeuticArea": "Maladies infectieuses",
      "responseTeam": "PODET",
      "startDate": "2-May-23",
      "projectedCompletion": "Été 2023",
      "status": "Complete",
      "language": "fr",
      "lastUpdated": "2025-03-07T16:24:17.223Z"
    },
    {
      "id": 1947,
      "title": "Le tocilizumab (Actemra) dans le traitement de la COVID-19 chez le patient hospitalisé",
      "url": "https://www.cadth.ca/fr/examen-des-traitements-contre-la-covid-19-0",
      "therapeuticArea": "Maladies infectieuses",
      "responseTeam": "Fournisseur externe",
      "startDate": "2-May-23",
      "projectedCompletion": "Été 2023",
      "status": "Complete",
      "language": "fr",
      "lastUpdated": "2025-03-07T16:24:17.254Z"
    },
    {
      "id": 1948,
      "title": "Le remdésivir (Veklury) dans le traitement de la COVID-19 en consultation externe",
      "url": "https://www.cadth.ca/fr/examen-des-traitements-contre-la-covid-19-0",
      "therapeuticArea": "Maladies infectieuses",
      "responseTeam": "PODET",
      "startDate": "4-May-23",
      "projectedCompletion": "Été 2023",
      "status": "Complete",
      "language": "fr",
      "lastUpdated": "2025-03-07T16:24:17.285Z"
    },
    {
      "id": 1949,
      "title": "Le nirmatrelvir-ritonavir (Paxlovid) dans le traitement de la COVID-19",
      "url": "https://www.cadth.ca/fr/examen-des-traitements-contre-la-covid-19-0",
      "therapeuticArea": "Maladies infectieuses",
      "responseTeam": "ADTEC",
      "startDate": "4-May-23",
      "projectedCompletion": "Été 2023",
      "status": "Complete",
      "language": "fr",
      "lastUpdated": "2025-03-07T16:24:17.316Z"
    },
    {
      "id": 1950,
      "title": "Les préparations de buprénorphine dans le traitement du trouble de consommation d’opioïdes en milieu correctionnel",
      "url": "https://www.cadth.ca/fr/les-preparations-de-buprenorphine-dans-le-traitement-du-trouble-de-consommation-dopioides-en-milieu",
      "therapeuticArea": "Douleur et soulagement de la douleur",
      "responseTeam": "Fournisseur externe",
      "startDate": "17-Nov-23",
      "projectedCompletion": "Printemps 2024",
      "status": "Complete",
      "language": "fr",
      "lastUpdated": "2025-03-07T16:24:17.348Z"
    },
    {
      "id": 1951,
      "title": "L’utilisation de traitements oncologiques en contexte de cancer du poumon non à petites cellules avancé présentant une mutation conductrice",
      "url": "https://www.cda-amc.ca/fr/lutilisation-de-traitements-oncologiques-en-contexte-de-cancer-du-poumon-non-petites-cellules",
      "therapeuticArea": "Oncologie",
      "responseTeam": "CCRE, Exactis",
      "startDate": "7-Dec-23",
      "projectedCompletion": "Été 2024",
      "status": "Complete",
      "language": "fr",
      "lastUpdated": "2025-03-07T16:24:17.379Z"
    },
    {
      "id": 1952,
      "title": "L’innocuité d’Ozempic dans le traitement du diabète de type 2",
      "url": "https://www.cadth.ca/fr/linnocuite-dozempic-dans-le-traitement-du-diabete-de-type-2",
      "therapeuticArea": "Diabète",
      "responseTeam": "RCEOM",
      "startDate": "4-Dec-23",
      "projectedCompletion": "Été 2024",
      "status": "Complete",
      "language": "fr",
      "lastUpdated": "2025-03-07T16:24:17.411Z"
    },
    {
      "id": 1953,
      "title": "Les inhibiteurs du peptide lié au gène de la calcitonine (CGRP) dans la prophylaxie de la migraine",
      "url": "https://www.cadth.ca/fr/les-inhibiteurs-du-peptide-lie-au-gene-de-la-calcitonine-cgrp-dans-la-prophylaxie-de-la-migraine",
      "therapeuticArea": "Douleur et soulagement de la douleur",
      "responseTeam": "Fournisseur externe, ADTEC, CAN-AIM",
      "startDate": "4-Feb-24",
      "projectedCompletion": "Hiver 2025",
      "status": "Complete",
      "language": "fr",
      "lastUpdated": "2025-03-07T16:24:17.442Z"
    },
    {
      "id": 1954,
      "title": "Efficacité et innocuité des traitements contre la gonorrhée sans complication",
      "url": "https://www.cda-amc.ca/fr/node/128800",
      "therapeuticArea": "Maladies infectieuses",
      "responseTeam": "Fournisseur externe",
      "startDate": "8-Jan-24",
      "projectedCompletion": "Été 2024",
      "status": "Complete",
      "language": "fr",
      "lastUpdated": "2025-03-07T16:24:17.473Z"
    },
    {
      "id": 1955,
      "title": "Le passage d’un inhibiteur du peptide lié au gène de la calcitonine à un autre dans la prophylaxie de la migraine",
      "url": "https://www.cda-amc.ca/fr/cgrp-inhibitors-migraine-prophylaxis",
      "therapeuticArea": "Douleur et soulagement de la douleur",
      "responseTeam": "Dr. Michael Law",
      "startDate": "29-Jan-24",
      "projectedCompletion": "Été 2024",
      "status": "Complete",
      "language": "fr",
      "lastUpdated": "2025-03-07T16:24:17.505Z"
    },
    {
      "id": 1956,
      "title": "Analyse de l’utilisation des médicaments dans le traitement de l’adénocarcinome à cellules rénales métastatique",
      "url": "https://www.cadth.ca/fr/analyse-de-lutilisation-des-medicaments-dans-le-traitement-de-ladenocarcinome-cellules-renales",
      "therapeuticArea": "Oncologie",
      "responseTeam": "CCRE",
      "startDate": "3-Apr-24",
      "projectedCompletion": "Hiver 2025",
      "status": "Complete",
      "language": "fr",
      "lastUpdated": "2025-03-07T16:24:17.536Z"
    },
    {
      "id": 1957,
      "title": "L’utilisation d’antidiabétiques pendant la grossesse",
      "url": "https://www.cadth.ca/fr/lutilisation-dantidiabetiques-pendant-la-grossesse",
      "therapeuticArea": "Diabète",
      "responseTeam": "RCEOM",
      "startDate": "4-Mar-24",
      "projectedCompletion": "Hiver 2025",
      "status": "Complete",
      "language": "fr",
      "lastUpdated": "2025-03-07T16:24:17.568Z"
    },
    {
      "id": 1958,
      "title": "Les agonistes du récepteur du GLP-1 et l’automutilation",
      "url": "https://www.cda-amc.ca/fr/les-agonistes-du-recepteur-du-glp-1-et-lautomutilation",
      "therapeuticArea": "Diabète",
      "responseTeam": "RCEOM",
      "startDate": "30-Jan-24",
      "projectedCompletion": "Hiver 2025",
      "status": "Active",
      "language": "fr",
      "lastUpdated": "2025-03-07T16:24:17.600Z"
    },
    {
      "id": 1959,
      "title": "Exploration du risque suicidaire et du risque d’automutilation associé aux agonistes du récepteur du peptide-1 de type glucagon",
      "url": "https://www.cadth.ca/fr/exploration-du-risque-suicidaire-et-du-risque-dautomutilation-associe-aux-agonistes-du-recepteur-du",
      "therapeuticArea": "Diabète",
      "responseTeam": "RCEOM",
      "startDate": "30-Jan-24",
      "projectedCompletion": "Printemps 2024",
      "status": "Complete",
      "language": "fr",
      "lastUpdated": "2025-03-07T16:24:17.631Z"
    },
    {
      "id": 1960,
      "title": "Les médicaments inhalés à action prolongée dans le traitement de la maladie pulmonaire obstructive chronique",
      "url": "https://www.cda-amc.ca/fr/les-medicaments-inhales-action-prolongee-dans-le-traitement-de-la-maladie-pulmonaire-obstructive",
      "therapeuticArea": "Respiratoire",
      "responseTeam": "PODET, ADTEC",
      "startDate": "15-Nov-23",
      "projectedCompletion": "Printemps 2026",
      "status": "Active",
      "language": "fr",
      "lastUpdated": "2025-03-07T16:24:17.662Z"
    },
    {
      "id": 1961,
      "title": "Les habitudes d’utilisation de médicaments inhalés à action prolongée dans le traitement de la maladie pulmonaire obstructive chronique",
      "url": "https://www.cadth.ca/fr/les-habitudes-dutilisation-de-medicaments-inhales-action-prolongee-dans-le-traitement-de-la-maladie",
      "therapeuticArea": "Respiratoire",
      "responseTeam": "RCEOM",
      "startDate": "15-Nov-23",
      "projectedCompletion": "Printemps 2025",
      "status": "Active",
      "language": "fr",
      "lastUpdated": "2025-03-07T16:24:17.693Z"
    },
    {
      "id": 1962,
      "title": "L’utilisation du nirmatrelvir-ritonavir et du remdésivir en milieu extrahospitalier au Canada",
      "url": "https://www.cadth.ca/fr/examen-des-traitements-contre-la-covid-19",
      "therapeuticArea": "Maladies infectieuses",
      "responseTeam": "RCEOM",
      "startDate": "2-May-23",
      "projectedCompletion": "Été 2023",
      "status": "Complete",
      "language": "fr",
      "lastUpdated": "2025-03-07T16:24:17.724Z"
    },
    {
      "id": 1963,
      "title": "Le recours aux inhibiteurs de PCSK9 dans le traitement de l’hypercholestérolémie familiale",
      "url": "https://www.cda-amc.ca/fr/lutilisation-des-inhibiteurs-de-pcsk9-dans-le-traitement-de-lhypercholesterolemie-familiale",
      "therapeuticArea": "Cardiovasculaire",
      "responseTeam": "RCEOM",
      "startDate": "7-Jun-24",
      "projectedCompletion": "Automne 2024",
      "status": "Complete",
      "language": "fr",
      "lastUpdated": "2025-03-07T16:24:17.755Z"
    },
    {
      "id": 1964,
      "title": "Les inhibiteurs de BRAF et de MEK dans le traitement des métastases cérébrales du mélanome actives ou symptomatiques",
      "url": "https://www.cda-amc.ca/fr/les-inhibiteurs-de-braf-et-de-mek-dans-le-traitement-des-metastases-cerebrales-du-melanome-actives",
      "therapeuticArea": "Oncologie",
      "responseTeam": "PODET",
      "startDate": "15-Jun-24",
      "projectedCompletion": "Été 2024",
      "status": "Complete",
      "language": "fr",
      "lastUpdated": "2025-03-07T16:24:17.787Z"
    },
    {
      "id": 1965,
      "title": "L’administration précoce de médicaments biologiques dans le traitement de maladies inflammatoires chroniques de l’intestin",
      "url": "https://www.cda-amc.ca/fr/ladministration-precoce-de-medicaments-biologiques-dans-le-traitement-de-maladies-inflammatoires",
      "therapeuticArea": "Gastro-intestinal",
      "responseTeam": "PODET",
      "startDate": "4-Jul-24",
      "projectedCompletion": "Été 2024",
      "status": "Complete",
      "language": "fr",
      "lastUpdated": "2025-03-07T16:24:17.818Z"
    },
    {
      "id": 1966,
      "title": "L’efficacité des inhibiteurs de PCSK9 dans le traitement de l’hypercholestérolémie familiale",
      "url": "https://www.cadth.ca/fr/lefficacite-des-inhibiteurs-de-pcsk9-dans-le-traitement-de-lhypercholesterolemie-familiale",
      "therapeuticArea": "Cardiovasculaire",
      "responseTeam": "RCEOM, ADTEC",
      "startDate": "8-Aug-24",
      "projectedCompletion": "Été 2025",
      "status": "Active",
      "language": "fr",
      "lastUpdated": "2025-03-07T16:24:17.849Z"
    },
    {
      "id": 1967,
      "title": "La reprise du traitement par les inhibiteurs de points de contrôle immunitaire – analyse d’utilisation",
      "url": "https://www.cda-amc.ca/fr/la-reprise-du-traitement-par-les-inhibiteurs-de-points-de-controle-immunitaire-analyse-dutilisation",
      "therapeuticArea": "Oncologie",
      "responseTeam": "CCRE",
      "startDate": "15-Aug-24",
      "projectedCompletion": "Été 2025",
      "status": "Active",
      "language": "fr",
      "lastUpdated": "2025-03-07T16:24:17.879Z"
    },
    {
      "id": 1968,
      "title": "Les données probantes comparatives sur l’hormonothérapie substitutive transdermique et orale",
      "url": null,
      "therapeuticArea": "Endocrinologie",
      "responseTeam": "PODET",
      "startDate": "24-Sep-24",
      "projectedCompletion": "Hiver 2025",
      "status": "Active",
      "language": "fr",
      "lastUpdated": "2025-03-07T16:24:17.911Z"
    },
    {
      "id": 1969,
      "title": "Les données probantes comparatives sur l’estrogénothérapie transdermique et orale dans le cadre des soins d’affirmation du genre",
      "url": null,
      "therapeuticArea": "Endocrinologie",
      "responseTeam": "PODET",
      "startDate": "24-Sep-24",
      "projectedCompletion": "Hiver 2025",
      "status": "Active",
      "language": "fr",
      "lastUpdated": "2025-03-07T16:24:17.941Z"
    },
    {
      "id": 1970,
      "title": "L’utilisation d’antipsychotiques injectables à action prolongée",
      "url": "https://www.cda-amc.ca/fr/lutilisation-dantipsychotiques-injectables-action-prolongee",
      "therapeuticArea": "Santé mentale",
      "responseTeam": "ODPRN, ADTEC",
      "startDate": "23-Oct-24",
      "projectedCompletion": "Printemps 2025",
      "status": "Active",
      "language": "fr",
      "lastUpdated": "2025-03-07T16:24:17.971Z"
    },
    {
      "id": 1971,
      "title": "Les nouveaux antiviraux visant à prévenir ou à traiter la grippe",
      "url": "https://www.cda-amc.ca/fr/les-nouveaux-antiviraux-visant-prevenir-ou-traiter-la-grippe",
      "therapeuticArea": "Maladies infectieuses",
      "responseTeam": "EPCM",
      "startDate": "4-Nov-24",
      "projectedCompletion": "Automne 2024",
      "status": "Complete",
      "language": "fr",
      "lastUpdated": "2025-03-07T16:24:18.002Z"
    },
    {
      "id": 1972,
      "title": "La prophylaxie postexposition contre la grippe A et la grippe B par des antiviraux",
      "url": null,
      "therapeuticArea": "Maladies infectieuses",
      "responseTeam": "Dr. Michael Law",
      "startDate": "11-Dec-24",
      "projectedCompletion": "Printemps 2025",
      "status": "Active",
      "language": "fr",
      "lastUpdated": "2025-03-07T16:24:18.033Z"
    },
    {
      "id": 1973,
      "title": "Les antiviraux dans la prévention ou le traitement d’infections à virus influenza d’origine zoonotique",
      "url": null,
      "therapeuticArea": "Maladies infectieuses",
      "responseTeam": "ADTEC",
      "startDate": "2-Dec-24",
      "projectedCompletion": "Printemps 2025",
      "status": "Active",
      "language": "fr",
      "lastUpdated": "2025-03-07T16:24:18.072Z"
    },
    {
      "id": 1974,
      "title": "Le rapport cout/efficacité des antiviraux dans la prévention ou le traitement de la grippe A, de la grippe B ou d’infections à virus influenza d’origine zoonotique",
      "url": null,
      "therapeuticArea": "Maladies infectieuses",
      "responseTeam": "ADTEC",
      "startDate": "9-Dec-24",
      "projectedCompletion": "Printemps 2025",
      "status": "Active",
      "language": "fr",
      "lastUpdated": "2025-03-07T16:24:18.103Z"
    },
    {
      "id": 1975,
      "title": "Les tendances de prescription d’hydromorphone au Canada de 2018 à 2024",
      "url": "https://www.cda-amc.ca/fr/les-tendances-de-prescription-dhydromorphone-au-canada-de-2018-2024",
      "therapeuticArea": "Douleur et soulagement de la douleur",
      "responseTeam": "ODPRN",
      "startDate": "2-Dec-24",
      "projectedCompletion": "Été 2025",
      "status": "Active",
      "language": "fr",
      "lastUpdated": "2025-03-07T16:24:18.134Z"
    }
  ],
  "lastUpdated": "2025-03-07T16:24:15.204Z"
}
